The Wegovy pill has a list price near $1,349 a month but self-pay offers start at $149, and Lilly's orforglipron pill (Foundayo) is also reported from about $149 a month. Prices depend on dose and channel.
The first weight-loss pills in the GLP-1 class are now on sale, and cost is the main question. Most figures below come from health and pharmacy guides, many of them commercial, so confirm prices with Novo Nordisk, Eli Lilly or your pharmacy before you buy.

Reported prices per month
| Product | Reported cost | Notes |
|---|---|---|
| Wegovy pill (oral semaglutide), list price | About $1,349 | Before insurance, coupons or discounts |
| Wegovy pill, NovoCare self-pay | $149 (1.5 mg), $199 (4 mg), $299 (9 mg and 25 mg) | Self-pay price; insurance may be lower, with some reports as low as $25 depending on the plan |
| Foundayo (orforglipron, Lilly) | Self-pay from about $149; one guide gives $149 to $349 | Approved April 1, 2026 for weight management; no confirmed list price in the sources |
| Wegovy injection, NovoCare self-pay | $349 for standard doses; $399 for 7.2 mg | A $199 introductory offer was also reported |
| Zepbound, LillyDirect | $299 to $449 | Without insurance |
Before you decide
- These are prescription drugs. A clinician decides whether one is appropriate and at what dose.
- The FDA has just required an eye-risk warning on every drug in the class; see our report on that warning.
- One source expects cash prices to start near $350 a month and fall toward about $245 over two years, a target, not a promise.
Not medical advice: Talk to a doctor about side effects, eligibility and monitoring. Check manufacturer sites for current prices.
Also on EcoPress: FDA Orders an Eye-Risk Warning on Every GLP-1 Drug: What Patients Should Know · Coffee, Flu Shots and Weight-Loss Surgery: How to Read This Week's Health Headlines
Sources and further reading: Drugs.com on Wegovy costs; Noom guide. Figures are as reported on the date of publication and may change.